140 results on '"Mani, Shailendra"'
Search Results
2. Berbamine prevents SARS-CoV-2 entry and transmission
3. Fangchinoline inhibits SARS-CoV-2 and MERS-CoV entry
4. Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infections
5. Antiviral activity of the human endogenous retrovirus‐R envelope protein against SARS‐CoV‐2
6. Assays for Detecting Henipavirus Antibodies
7. Designing and characterization of a SARS-CoV-2 immunogen with receptor binding motif grafted on a protein scaffold: An epitope-focused vaccine approach
8. High failure rate of ChAdOx1-nCoV19 immunization against asymptomatic infection in healthcare workers during a Delta variant surge
9. Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses
10. A rapid point-of-care population-scale dipstick assay to identify and differentiate SARS-CoV-2 variants in COVID-19-positive patients.
11. Characterization of a broadly cross reactive tetravalent human monoclonal antibody, recognizing conformational epitopes in receptor binding domain of SARS-CoV-2
12. Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus
13. Robust dengue virus infection in bat cells and limited innate immune responses coupled with positive serology from bats in IndoMalaya and Australasia
14. The “Investigating and translating genomic evidence for public health response to SARS-CoV-2 (INSIDE SARS-CoV-2)” project – Network of excellence.
15. SARS-CoV-2 antibodies cross-react and enhance dengue infection
16. SARS-CoV-2 antibodies cross-react and enhance dengue infection
17. Evaluation of Ayush-64 (a Polyherbal Formulation) and Its Ingredients in the Syrian Hamster Model for SARS-CoV-2 Infection Reveals the Preventative Potential of Alstonia scholaris
18. Dampened NLRP3-mediated inflammation in bats and implications for a special viral reservoir host
19. A rapid point-of-care population-scale dipstick assay to identify and differentiate SARS-CoV-2 variants in COVID-19-positive patients
20. Serological Cross Reactivity between Zika and Dengue Viruses in Experimentally Infected Monkeys
21. Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin
22. Host inducible-HSP70A1A is an irresistible drug target to combat SARS-CoV-2 infection and pathogenesis
23. Pharmacological potential of Withania somnifera (L.) Dunal and Tinospora cordifolia (Willd.) Miers on the experimental models of COVID-19, T cell differentiation, and neutrophil functions
24. A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern
25. Immunogenicity and Safety of Booster Dose of Sputnik Light Vector Vaccine against COVID-19 in Adult Indian Subjects-A Phase III, Randomized, Open Label, Multicentre -Parallel study
26. Proinflammatory Innate Cytokines and Distinct Metabolomic Signatures Shape the T Cell Response in Active COVID-19
27. Prophylactic treatment of Glycyrrhiza glabra mitigates COVID-19 pathology through inhibition of pro-inflammatory cytokines in the hamster model and NETosis
28. A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant
29. A broadly neutralising monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV2 variant of concerns
30. Proinflammatory innate cytokines and metabolomic signatures shape the T cell response in active COVID-19
31. Omicron Sub-Lineage BA.5 Infection Causes Attenuated Pathology and Results in Robust Protection in Omicron Recovered hACE2 Transgenic Mice
32. The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41
33. A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 delta variant
34. A Cold Chain-Independent Specimen Collection and Transport Medium Improves Diagnostic Sensitivity and Minimizes Biosafety Challenges of COVID-19 Molecular Diagnosis
35. Effect of Prophylactic Use of Intranasal Oil Formulations in the Hamster Model of COVID-19
36. Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2
37. RNA-Protein Interaction Analysis of SARS-CoV-2 5′ and 3′ Untranslated Regions Reveals a Role of Lysosome-Associated Membrane Protein-2a during Viral Infection
38. Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative
39. Effect of prophylactic use of intra-nasal oil formulations in the hamster model of Covid-19
40. Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model
41. Wuhan to World: The COVID-19 Pandemic
42. Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses in vivo and Inhibit Viral Replication in vitro
43. High failure rate of ChAdOx1-nCoV19 immunization against asymptomatic infection in healthcare workers during a Delta variant surge: a case for continued use of masks post-vaccination
44. RNA-protein interaction analysis of SARS-CoV-2 5’- and 3’-untranslated regions identifies an antiviral role of lysosome-associated membrane protein-2
45. Cellular Immune Responses are Preserved and May Contribute to Chadox1 ChAdOx1 nCoV-19 Vaccine Effectiveness Against Infection Due to SARS-CoV-2 B·1·617·2 Delta Variant Despite Reduced Virus Neutralisation
46. Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment
47. Identification of an anti–SARS–CoV-2 receptor-binding domain–directed human monoclonal antibody from a naïve semisynthetic library
48. Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment immunogen
49. A Luminex based serological assay for detecting IgM and IgG antibody response in SARS-CoV2 patients
50. Robust dengue virus infection in bat cells and limited innate immune responses coupled with positive serology from bats in IndoMalaya and Australasia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.